Abbott Laboratories vs. Bolt Biotherapeutics, Inc. Common Stock
Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABT | BOLT | |
|---|---|---|
| Market Cap | $199.88 billion | $15.53 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | BOLT | |
|---|---|---|
| Dividend Yield | 2.22% | — |
ABT and BOLT split the dividend factors evenly.
Risk & Sentiment
| ABT | BOLT | |
|---|---|---|
| Short Interest | 0.57% | 22.62% |
ABT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, BOLT overview, BOLT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
